Toboroz
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
NCT07575672· 3. fázis· Second Affiliated Hospital, Zhejiang University, School of Medicine· Forrás
Contact: Xiangqing Kong, MD
Még nem toboroz
A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT07753369· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Jian Yong Li, doctor
Toboroz
Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients
NCT07663253· Shanghai Zhongshan Hospital· Forrás
Contact: Xiaoyan Qu
Toboroz
RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)
NCT07416474· 3. fázis· RemeGen Co., Ltd.· Forrás
Contact: Yongfeng Yang
Még nem toboroz
Left Ventricular Myocardial Work for Predicting Response to CRT
NCT07319065· First Hospital of China Medical University· Forrás
Contact: Yonghong Yong
Még nem toboroz
KN5501 Cell Injection for Refractory SLE(CLEAR)
NCT07358988· 1. fázis· Ruitherapeutics Co., LTD· Forrás
Contact: Director of Rheumatology Department
Toboroz
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
NCT07143045· Alpha Biopharma (Jiangsu) Co., Ltd.· Forrás
Contact: Wen Gao Professor
Toboroz
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT07127822· 2. fázis· Peking University· Forrás
Contact: Hao Wu
Még nem toboroz
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
NCT07238959· Shanghai Changzheng Hospital· Forrás
Contact: Shancheng Ren, MD,PhD
Toboroz
TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer
NCT07044908· 1/2. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Yanhong Gu, Doctor
Toboroz
Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy
NCT07823049· 3. fázis· Evopoint Biosciences Inc.· Forrás
Contact: Yingjie zhao
Toboroz
A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer
NCT07003074· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Yongmei Yin, Doctor
Még nem toboroz
Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer
NCT07007286· Peking University First Hospital· Forrás
Contact: Chuanlong zhu
Toboroz
A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer
NCT07455019· 2. fázis· The First Affiliated Hospital with Nanjing Medical University· Forrás
Contact: Ge Xiao Lin
Toboroz
Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma
NCT06829771· 1/2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Lei Fan, Doctor
Toboroz
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
NCT06821503· 1/2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Kuirong Jiang, Doctor
Még nem toboroz
Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)
NCT06859931· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Wenfeng Tan, Doctor
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy
NCT06797297· 2. fázis· Innovent Biologics (Suzhou) Co. Ltd.· Forrás
Fut, nem toboroz
Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer
NCT06702618· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Toboroz
Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
NCT06754891· 1. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Hongjie Zhang, Doctor
Toboroz
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study
NCT06770296· 1. fázis· The First Affiliated Hospital with Nanjing Medical University· Forrás
Contact: Yongmei Yin, Ph.D
Fut, nem toboroz
Neoadjuvant Therapy for Locally Advanced Rectal Cancer
NCT06853769· Korai 1. fázis· The First Affiliated Hospital with Nanjing Medical University· Forrás
Toboroz
A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
NCT06496490· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Renhua Guo, Doctor
Toboroz
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
NCT06431490· 1/2. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Xiaofeng Chen, Doctor
Toboroz
Goal-directed Enteral Nutritional Perioperative Management
NCT06510543· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Forrás
Contact: Jinhua Luo, M.D.
Toboroz
Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
NCT06767813· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Kuirong Jiang, Doctor
Toboroz
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
NCT06079983· 3. fázis· Jiangsu Alphamab Biopharmaceuticals Co., Ltd· Forrás
Contact: Yongmei Yin
Fut, nem toboroz
Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL
NCT06093841· 2. fázis· Shanghai Ming Ju Biotechnology Co., Ltd.· Forrás
Fut, nem toboroz
A Study of Telitacicept for IgA Nephropathy (TELIGAN)
NCT05799287· 3. fázis· RemeGen Co., Ltd.· Forrás
Fut, nem toboroz
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
NCT04849728· 3. fázis· Inventiva Pharma· Forrás
Meghívásos bevonás
Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection
NCT04762459· 3. fázis· Chinese Academy of Medical Sciences· Forrás
Toboroz
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
NCT04532606· 4. fázis· Peking University First Hospital· Forrás
Contact: Cun-Ming Liu, MD
Fut, nem toboroz
Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study)
NCT04765605· Hangzhou Endonom Medtech Co., Ltd.· Forrás
Toboroz
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
NCT04685226· 1/2. fázis· Beijing InnoCare Pharma Tech Co., Ltd.· Forrás
Contact: Yongqian Shu, MD
Fut, nem toboroz
Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer
NCT06926088· The First Affiliated Hospital with Nanjing Medical University· Forrás